Skip to main content

nl
fr
en
de

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Information for professionals

Home
Human medicines
Health Products
Medical devices and their accessories
Materiovigilance

Materiovigilance

What shall be notified?

Who should notify?

When must incidents be notified?

How should incidents be notified?

Last updated on 20/05/2009

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

31/03/2020

Coronavirus: what medicinal products are used in the fight against COVID-19?

31/03/2020

Coronavirus: the FAMHP seizes postal packages containing counterfeit and other illegal medicinal products against COVID-19

31/03/2020

Operation PANGEA XIII: Belgian customs and the FAMHP seize 203 packages containing over 23 000 illicit or counterfeit products

30/03/2020

Nitrosamines in medicinal products: report results of risk assessments for impurities

All news

© 2016 - FAMHP

Site map
Disclaimer